Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961128 · ClinicalTrials.gov registry record · NA
RPFNA Assessment of Exercise Effect in Breast Cancer
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01961128 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 2 participants.
The verdict
NCT01961128, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study is being done to see if the investigators can measure changes that occur in breast tissue when women at risk of developing breast cancer start an exercise program. The investigators are interested in studying this because research shows that women who exercise regularly are less likely to develop breast cancer, but there is not very much information explaining how exercise could affect breast cells in a way to prevent cancer from occurring. In this research study the investigators will use a research technique called breast random fine needle aspiration (RPFNA) to test breast cells for their shape and how they look. The investigators will look at breast cells before and after a participant takes part in an exercise program to see if the investigators are able to see any changes in breast cells that could have happened due to the exercise program. This research will help us to develop larger projects to see if exercise programs could be helpful in preventing breast cancer.
Interventions
- BEHAVIORAL Exercise Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01961128
The ClinicalTrials.gov registry entry for NCT01961128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exercise Intervention is the first listed.
NCT01961128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01961128 about?
NCT01961128 is a clinical study titled "RPFNA Assessment of Exercise Effect in Breast Cancer". This study is being done to see if the investigators can measure changes that occur in breast tissue when women at risk of developing breast cancer start an exercise program. The investigators are interested in studying this because research shows that women who exercise regularly are less likely to...
What is the current status of trial NCT01961128?
This trial is currently completed. It is a NA study. The enrollment target is 2 participants. The study started on 2011-10. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01961128?
The interventions under investigation include: Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01961128?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.